M.F. Oliver

7.0k total citations
112 papers, 4.6k citations indexed

About

M.F. Oliver is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, M.F. Oliver has authored 112 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Cardiology and Cardiovascular Medicine, 22 papers in Endocrinology, Diabetes and Metabolism and 20 papers in Surgery. Recurrent topics in M.F. Oliver's work include Cardiac Imaging and Diagnostics (15 papers), Lipoproteins and Cardiovascular Health (14 papers) and Cardiovascular Function and Risk Factors (13 papers). M.F. Oliver is often cited by papers focused on Cardiac Imaging and Diagnostics (15 papers), Lipoproteins and Cardiovascular Health (14 papers) and Cardiovascular Function and Risk Factors (13 papers). M.F. Oliver collaborates with scholars based in United Kingdom, Finland and Ireland. M.F. Oliver's co-authors include G.S. Boyd, V.A. Kurien, K. W. Donald, Desmond G. Julian, P. Yates, Rudolph A. Riemersma, D.M. Lawrie, Mary Fulton, Richard C. Strange and W. Lutz and has published in prestigious journals such as The Lancet, Circulation and Circulation Research.

In The Last Decade

M.F. Oliver

108 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.F. Oliver United Kingdom 42 1.7k 1.1k 913 720 592 112 4.6k
D J Coltart United Kingdom 30 2.2k 1.3× 1.2k 1.1× 433 0.5× 236 0.3× 497 0.8× 122 4.1k
Anton C. Schoolwerth United States 28 2.1k 1.3× 1.0k 1.0× 764 0.8× 371 0.5× 1.3k 2.2× 90 6.9k
Peter M. Schofield United Kingdom 35 2.1k 1.2× 1.9k 1.8× 437 0.5× 777 1.1× 1.6k 2.7× 114 6.9k
Mattias Aurell Sweden 36 1.4k 0.8× 538 0.5× 849 0.9× 341 0.5× 437 0.7× 191 4.6k
John Goudevenos Greece 38 3.1k 1.8× 1.6k 1.6× 723 0.8× 326 0.5× 556 0.9× 194 6.3k
M. F. Oliver United Kingdom 20 692 0.4× 675 0.6× 587 0.6× 481 0.7× 386 0.7× 49 2.6k
A. J. M. Donker Netherlands 40 1.6k 0.9× 1.3k 1.2× 1.2k 1.3× 350 0.5× 788 1.3× 128 5.8k
Harold W. Schnaper United States 30 2.1k 1.2× 867 0.8× 506 0.6× 221 0.3× 277 0.5× 101 3.7k
Walter Riesen Switzerland 32 952 0.6× 746 0.7× 1.1k 1.2× 188 0.3× 555 0.9× 133 3.6k
Izabella Lipinska United States 32 1.7k 1.0× 670 0.6× 792 0.9× 342 0.5× 615 1.0× 46 5.2k

Countries citing papers authored by M.F. Oliver

Since Specialization
Citations

This map shows the geographic impact of M.F. Oliver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.F. Oliver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.F. Oliver more than expected).

Fields of papers citing papers by M.F. Oliver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.F. Oliver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.F. Oliver. The network helps show where M.F. Oliver may publish in the future.

Co-authorship network of co-authors of M.F. Oliver

This figure shows the co-authorship network connecting the top 25 collaborators of M.F. Oliver. A scholar is included among the top collaborators of M.F. Oliver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.F. Oliver. M.F. Oliver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Oliver, M.F.. (1995). Statins prevent coronary heart disease. The Lancet. 346(8987). 1378–1379. 16 indexed citations
3.
Crook, David, et al.. (1994). Dietary polyunsaturated fatty acids and composition of human aortic plaques. The Lancet. 344(8931). 1195–1196. 45 indexed citations
4.
Oliver, M.F., et al.. (1992). [Arterial hypertension in the adolescent: its possible relation to the salt taste threshold].. PubMed. 45(4). 227–31. 9 indexed citations
5.
Oliver, M.F.. (1991). Might treatment of hypercholesterolaemia increase non-cardiac mortality?. The Lancet. 337(8756). 1529–1531. 98 indexed citations
6.
Oliver, M.F.. (1989). Crisis in cardiovascular research in Britain.. Heart. 62(4). 325–327. 4 indexed citations
7.
Oliver, M.F.. (1989). CIGARETTE SMOKING, POLYUNSATURATED FATS, LINOLEIC ACID, AND CORONARY HEART DISEASE. The Lancet. 333(8649). 1241–1243. 35 indexed citations
8.
Notghi, A., Rudolph A. Riemersma, J. L. Anderton, & M.F. Oliver. (1989). Effect of pindolol versus atenolol on lipid profile in hypertensive patients. Atherosclerosis. 77(2-3). 215–220. 7 indexed citations
9.
Oliver, M.F.. (1987). Dietary fat and coronary heart disease.. Heart. 58(5). 423–428. 30 indexed citations
10.
Thomson, M, Mary Fulton, David Wood, et al.. (1985). A comparison of the nutrient intake of some Scotsmen with dietary recommendations.. PubMed. 39(6). 443–55. 22 indexed citations
11.
Oliver, M.F.. (1981). DIET AND CORONARY HEART DISEASE. British Medical Bulletin. 37(1). 49–58. 44 indexed citations
12.
Geizerová, H, I Gyárfás, Gudrun Lamm, et al.. (1979). [Primary prevention of ischemic heart disease using clofibrate. Cooperative epidemiological study].. PubMed. 118(15). 449–53.
13.
Logan, Robert L., R. A. Riemersma, M.F. Oliver, et al.. (1978). The Edinburgh-Stockholm Study of Coronary Heart Disease Risk Factors: A Summary. Advances in experimental medicine and biology. 109. 287–294. 1 indexed citations
14.
Oliver, M.F., et al.. (1976). Antilipolytic therapy in angina pectoris. Reduction of exercise-induced ST segment depression.. Heart. 38(11). 1204–1208. 19 indexed citations
15.
Radford, Dorothy J. & M.F. Oliver. (1973). Oral Contraceptives and Myocardial Infarction. BMJ. 3(5877). 428–430. 64 indexed citations
16.
Kurien, V.A. & M.F. Oliver. (1966). SERUM-FREE-FATTY-ACIDS AFTER ACUTE MYOCARDIAL INFARCTION AND CEREBRAL VASCULAR OCCLUSION. The Lancet. 288(7455). 122–127. 132 indexed citations
17.
Oliver, M.F., et al.. (1965). EFFECT OF ETHYLCHLORO-PHENOXYISOBUTYRATE ON WEIGHT, PLASMA VOLUME, TOTAL BODY-WATER, AND FREE FATTY ACIDS. The Lancet. 286(7419). 924–926. 20 indexed citations
18.
Oliver, M.F.. (1963). Further observations on the effects of atromid and of ethyl chlorophenoxyisobutyrate on serum lipid levels. Journal of Atherosclerosis Research. 3(5-6). 427–444. 95 indexed citations
19.
Oliver, M.F.. (1962). ISCHÆMIC HEART-DISEASE. The Lancet. 279(7231). 653–656. 8 indexed citations
20.
Oliver, M.F. & G.S. Boyd. (1957). EFFECT OF PHENYLETHYLACETIC ACID AND ITS AMIDE (HYPOSTEROL) ON THE CIRCULATING LIPIDS AND LIPOPROTEINS IN MAN. The Lancet. 270(7000). 829–830. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026